Skip to main content
Equibles

Michael Raab

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Michael Raab

Earlier roles on record: Board Member at Tempest Therapeutics, Inc. (TPST) until May 22, 2026. Tempest Therapeutics, Inc. reported in an 8-K filed May 22, 2026 that Michael Raab resigned as Board of Directors, effective May 22, 2026.

“On May 22, 2026, each of Mr. Stephen Brady, Mr. Michael Raab and Ms. Christine Pellizzari notified Tempest Therapeutics, Inc. (the “Company”) of his or her resignation from the Board of Directors of the Company (the “Board”), effective as of such date.”
Tempest Therapeutics, Inc. Form 8-K, filed May 22, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.